VVM
Versant Venture Management Portfolio holdings
AUM
$212M
1-Year Est. Return
25.16%
1 Year Est. Return
+25.16%
AUM
$212M
AUM Growth
+$130M
(+159%)
Holding
9
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LENZ
1
LENZ Therapeutics
LENZ
$563M
| $124M | 58.25% |
+2,656,888
|
|
||
2
Monte Rosa Therapeutics
GLUE
$1.01B
| $41.9M | 19.72% |
5,652,922
|
|
||
|
JBIO
3
Jade Biosciences
JBIO
$783M
| $13.2M | 6.2% |
1,525,820
|
|
||
4
CRISPR Therapeutics
CRSP
$5.32B
| $9.65M | 4.54% |
148,831
-349,727
|
|
||
5
Skye Bioscience
SKYE
$29.8M
| $7.89M | 3.71% |
2,007,704
|
|
||
|
CTNM
6
Contineum Therapeutics
CTNM
$429M
| $6.38M | 3% |
542,628
|
|
||
7
Repare Therapeutics
RPTX
$92.3M
| $4.66M | 2.19% |
2,646,657
|
|
||
8
Tempest Therapeutics
TPST
$15.4M
| $2.77M | 1.31% |
269,772
|
|
||
|
ADVM
9
DELISTED
Adverum Biotechnologies
ADVM
| $2.3M | 1.08% |
506,821
|
|